Corcept Therapeutics Inc (CORT)
22.48
-0.52
(-2.26%)
USD |
NASDAQ |
Apr 24, 16:00
22.50
+0.02
(+0.11%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (Quarterly): 17.10M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.10M |
| September 30, 2023 | -109.57M |
| June 30, 2023 | -24.10M |
| March 31, 2023 | 207.48M |
| December 31, 2022 | -17.24M |
| September 30, 2022 | -4.79M |
| June 30, 2022 | -41.80M |
| March 31, 2022 | -50.50M |
| December 31, 2021 | 140.47M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 24.74M |
| March 31, 2021 | -3.284M |
| December 31, 2020 | 11.22M |
| September 30, 2020 | -64.27M |
| June 30, 2020 | -85.94M |
| March 31, 2020 | 19.73M |
| December 31, 2019 | -61.99M |
| September 30, 2019 | -54.32M |
| June 30, 2019 | -1.156M |
| March 31, 2019 | -0.367M |
| December 31, 2018 | -1.757M |
| September 30, 2018 | -33.51M |
| June 30, 2018 | -21.21M |
| March 31, 2018 | -34.29M |
| December 31, 2017 | -27.45M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.65M |
| June 30, 2017 | -14.95M |
| March 31, 2017 | -19.41M |
| December 31, 2016 | -0.075M |
| September 30, 2016 | -0.09M |
| June 30, 2016 | -0.007M |
| March 31, 2016 | -0.022M |
| December 31, 2015 | 0.017M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.034M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.016M |
| June 30, 2014 | -0.048M |
| March 31, 2014 | -0.11M |
| December 31, 2013 | -0.04M |
| September 30, 2013 | -0.065M |
| June 30, 2013 | -0.004M |
| March 31, 2013 | -0.018M |
| December 31, 2012 | -0.058M |
| September 30, 2012 | -0.052M |
| June 30, 2012 | -0.034M |
| March 31, 2012 | -0.007M |
| December 31, 2011 | -0.025M |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-109.57M
Minimum
Sep 2023
207.48M
Maximum
Mar 2023
-6.527M
Average
-17.24M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | -107.02M |
| Alnylam Pharmaceuticals Inc | -240.66M |
| Catalyst Pharmaceuticals Inc | -38.32M |
| United Therapeutics Corp | 42.10M |
| XOMA Corp | 5.511M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.887M |
| Cash from Financing (Quarterly) | 0.766M |
| Free Cash Flow | 126.90M |
| Free Cash Flow Per Share (Quarterly) | 0.0531 |
| Free Cash Flow to Equity (Quarterly) | 5.887M |
| Free Cash Flow to Firm (Quarterly) | 5.887M |
| Free Cash Flow Yield | 5.05% |